BOCA RATON, Fla., July 20, 2016 /PRNewswire/ -- Sensus
Healthcare, Inc. (NASDAQ: SRTSU), a medical device company
specializing in the treatment of non-melanoma skin cancers and
other skin conditions, such as keloids, with superficial radiation
therapy, today announced that it will report its second quarter
2016 financial results on Thursday, August 4, 2016 after the
market close.
The Company will hold a conference call with the investment
community on Thursday, August 4, 2016 at 4:30 p.m.
Eastern Time featuring remarks by Joseph Sardano, President
and CEO, and Arthur Levine, CFO. The dial-in numbers for the
conference call are 1-877-870-4263 (Toll Free), 1-412-317-0790
(International) and 1-855-669-9657 (Canada Toll Free). Please ask
the operator to join you into the Sensus Healthcare Call.
A live webcast of the conference call will be available online
which can be accessed through the Investor Relations section of
Sensus' website,
http://investors.sensushealthcare.com/events-and-presentations.
Please allow extra time prior to the call to visit the site
and download any necessary software to listen to the live
broadcast.
For interested individuals unable to join the conference call, a
replay of the webcast will remain available on
http://investors.sensushealthcare.com/events-and-presentations for
30 days following the call.
About Sensus
Sensus Healthcare, Inc. is a medical
device company that is committed to enabling non-invasive and
cost-effective treatment of non-melanoma skin cancers and keloids.
Sensus uses a proprietary low energy x-ray radiation technology
known as superficial radiation therapy (SRT), which is a result of
over a decade of dedicated research and development activities.
Sensus has successfully incorporated the SRT therapy into its
portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™.
To date, the SRT technology has been used to effectively and safely
treat oncological and non-oncological skin conditions in thousands
of patients. For more information, visit
http://www.sensushealthcare.com.
Investor Relations:
Jeffrey
Goldberger / Allison Soss
KCSA Strategic Communications
Phone: 212-896-1249 / 212-896-1267
Email: jgoldberger@kcsa.com / asoss@kcsa.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sensus-healthcare-to-announce-second-quarter-2016-results-on-august-4-2016-300301043.html
SOURCE Sensus Healthcare, Inc.